Where Success Begins

Science-led integrated drug discovery: medicinal and synthetic chemistry, computational chemistry, in vitro biosciences, DMPK, compound management and diversity and fragment libraries.

Read more

About Us

BioAscent is a leading provider of integrated drug discovery services

Founded in 2013, BioAscent is a leading provider of integrated drug discovery services based at the former Organon / MSD R&D site in Newhouse, Scotland, UK. Our drug discovery services include de novo assay development, target analysis and bespoke screening strategies, compound screening (including HTS), medicinal and synthetic chemistry, computational chemistry and compound management, all with access to in-house diversity and fragment libraries.

Read more

News

BioAscent obtains cyber essentials plus accreditation

12 June 2024


BioAscent has received Cyber Essentials Plus certification, demonstrating the company’s commitment to cyber security.Cyb...

Read more

BioAscent reports year-on-year growth for in silico discovery services

10 June 2024


BioAscent has experienced continued growth in demand for its in silico discovery services. Despite the challenging marke...

Read more

Meet the team: Michael Kiczun

30 May 2024


In our latest Meet the Team blog, we hear from Michael Kiczun, Senior Scientist and Team Leader in the medicinal chemist...

Read more

Supercharging Reaction Optimisation with 'Pool and Split'

22 May 2024


Welcome to a world where molecules wield extraordinary power, capable of healing, rejuvenating, and transforming lives....

Read more

Integrated Drug Discovery


Science-led drug discovery

Get in Touch

Let's talk about how we can maximise your drug discovery success.

Contact